REFERENCES
- Mullins J. J., Peters J., Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 renin gene. Nature 1990; 344: 541–544
- Lemmer B., Mattes A., Böhm M., Ganten D. Circadian blood pressure variation in transgenic hypertensive rats. Hypertension 1993; 22: 97–101
- Witte K., Lemmer B. Free-running rhythms in blood pressure and heart rate in normotensive and transgenic hypertensive rats. Chronobiol. Int. 1995; 12: 237–247
- Springate J. E., Feld L. G., Ganten D. Renal function in hypertensive rats transgenic for mouse renin gene. Am. J. Physiol. 1994; 266: F731–F737
- Dunn W. R., Gardiner S. M. Differential alteration in vascular structure of resistance arteries isolated from the cerebral and mesenteric vascular beds of transgenic [(mRen2)27], hypertensive rats. Hypertension 1997; 29: 1140–1147
- Villarreal F. J., Mackenna D. A., Omens J. H., Dillmann W. H. Myocardial remodeling in hypertensive REN-2 transgenic rats. Hypertension 1995; 25: 98–104
- Moncada S., Palmer R. M. J., Higgs E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 1991; 43: 109–142
- Lahera V., Navarro-Cid J., Cachofeiro V., Garola-Eston J., Ruilope L. M. Nitric oxide, the kidney, and hypertension. Am. J. Hypertens. 1997; 10: 129–140
- Suzuki H., Ikenaga H., Hishikawa K., Nakaki T., Kato R., Saruta T. Increases in NO−2/NO−3 excretion in the urine as an indicator of endothelium-derived relaxing factor during elevation of blood pressure. Clin. Sci. 1992; 82: 631–634
- Böger R. H., Bode-Böger S. M., Gerecke U., Gutzki F. M., Tslkas D., Frölich J. C. Urinary NO−3 excretion as an indicator of nitric oxide formation in vivo during oral administration of L-arginine or L-NAME in rats. Clin. Exp. Pharmacol. Physiol. 1996; 23: 11–15
- Baylis C., Vallance P. Measurement of nitrite and nitrate levels in plasma and urine—what does this measure tell us about the activity of the endogenous nitric oxide system?. Curr. Opin. Nephrol. Hypertens. 1998; 7: 59–62
- Globig S., Witte K., Lemmer B. Urinary excretion of nitric oxide, cyclic GMP and catecholamine during rest and activity period in transgenic rats. Chronobiol. Int. 1999; 16: 305–314
- Shan Z., Dai S., Su D. Relationship between baroreceptor function and end-organ damage in spontaneously hypertensive rats. Am. J. Physiol. 1999; 277: H1200–H1206
- La Rovere M. T., Bigger J. T., Marcus F. I., Mortara A., Schwartz P. J. Baroreflex sensitivity and heart rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 1998; 351: 478–484
- Witte K., Zuther P., Lemmer B. Analysis of telemetric time series data for periodic components using DQ-FIT. Chronobiol. Int. 1997; 14: 561–574
- Oosting J., Struijker-Boudier H. A. J., Janssen B. J. A. Validation of a continuous baroreceptor reflex sensitivity index calculated from spontaneous fluctuations of blood pressure and pulse interval in rats. J. Hypertens. 1997; 15: 391–399
- Green L. C., Wagner D. A., Glogowski J., Skipper G. L., Wishnok J. S., Tannenbaum S. R. Analysis of nitrate, nitrite and 15N-nitrate in biological fluids. Anal. Biochem. 1982; 126: 131–138
- Ackermann H. BiAS. Biometrische Analyse von Stichproben. Epsilon-Verlag: Hochheim-Darmstadt 1997
- Mattes A., Witte K., Hohmann W., Lemmer B. PHARMFIT—a nonlinear fitting program for pharmacology. Chronobiol. Int. 1991; 8: 460–476
- Witte K., Lemmer B. Development of inverse circadian blood pressure pattern in transgenic hypertensive TGR (mREN2)27 rats. Chronobiol. Int. 1999; 16: 293–303
- Gaudet E., Godwin S. J., Head G. A. Effects of central infusion of ANG II and losartan on the cardiac baroreflex in rabbits. Am. J. Physiol. 2000; 278: H558–H566
- Wilfert K., Drischel K., Unbehaun A., Guski H., Persson P. B., Stauss H. M. Vascular response to angiotensin II in atherosclerosis: role of the baroreflex. Hypertension 2000; 35: 685–690
- Averill D. B., Diz D. I. Angiotensin peptides and baroreflex control of sympathetic outflow: pathways and mechanisms of the medulla oblongata. Brain Res. Bull. 2000; 51: 119–128
- Oosting J., Struijker-Boudier H. A. J., Janssen B. J. A. Autonomic control of ultradian and circadian rhythms of blood pressure, heart rate, and baroreflex sensitivity in spontaneously hypertensive rats. J. Hypertens. 1997; 15: 401–410
- Lantelme P., Ming L., Sassard J. Decreased cardiac baroreflex sensitivity is not due to cardiac hypertrophy in NG-nitro-L-arginine methyl ester-induced hypertension. J. Hypertens. 1994; 12: 791–795
- Deng L. Y., Thibault G., Schiffin E. L. Effect of hypertension induced by nitric oxide synthase inhibition on structure and function of resistance arteries in the rat. Clin. Exp. Hypertens. 1993; 15: 527–537
- Gardiner S. M., Compton A. M., Bennett T., Palmer R. M., Moncada S. Regional hemodynamic changes during oral ingestion of NG-monomethyl-L-arginine methyl ester or NG-nitro-L-arginine-methyl ester in conscious Brattelboro rats. Br. J. Pharmacol. 1990; 101: 10–12
- Togashi H., Sakuma I., Yoshioka M., Kobayashi T., Yasuda H., Kitabatake A., Salto H., Gross S. S., Levi R. A. central nervous system action of nitric oxide in blood pressure regulation. J. Pharmacol. Exp. Ther. 1992; 262: 343–347